Autolus Therapeutics (AUTL) Retained Earnings (2017 - 2026)
Autolus Therapeutics' (AUTL) quarterly Retained Earnings came in at $1.6 billion in Q4 2025, up 0.93% YoY from $1.6 billion in Q4 2024, and little changed on a QoQ basis from $1.6 billion in Q3 2025.
Autolus Therapeutics (AUTL) Retained Earnings (2017 - 2026) Analysis & Trends
Autolus Therapeutics (AUTL) has 9 years of Retained Earnings data on file, last reported at $1.6 billion in Q4 2025.
- Quarterly Retained Earnings rose 0.93% year-over-year to $1.6 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.6 billion (up 0.93% YoY) and the FY2025 annual result came in at $1.6 billion, up 0.93% from the prior year.
- Retained Earnings steadied at $1.6 billion in Q4 2025, from $1.6 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $1.6 billion in Q4 2025 to a low of $716.5 million in Q1 2021.
- A 5-year average of $1.2 billion and a median of $1.0 billion in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2024 — Retained Earnings soared 52.68% — and 2025, when it rose 0.93%.
- Tracing AUTL's Retained Earnings over 5 years: stood at $843.1 million in 2021, then grew by 19.51% to $1.0 billion in 2022, then increased by 1.12% to $1.0 billion in 2023, then jumped by 52.67% to $1.6 billion in 2024, then grew by 0.93% to $1.6 billion in 2025.
- The last three Retained Earnings figures came in at $1.6 billion (Q4 2025), $1.6 billion (Q3 2025), and $1.6 billion (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Autolus Therapeutics | 763.37 Mn | 561.74 Mn | 25.22 Mn | 1.58 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.58 Bn |
| Dec 31, 2025 | 1.57 Bn |
| Sep 30, 2025 | 1.57 Bn |
| Jun 30, 2025 | 1.56 Bn |
| Mar 31, 2025 | 1.56 Bn |
| Dec 31, 2024 | 1.56 Bn |
| Sep 30, 2024 | 1.55 Bn |
| Jun 30, 2024 | 1.55 Bn |
| Mar 31, 2024 | 1.54 Bn |
| Dec 31, 2023 | 1.02 Bn |
| Sep 30, 2023 | 1.02 Bn |
| Jun 30, 2023 | 1.01 Bn |
| Mar 31, 2023 | 1.01 Bn |
| Dec 31, 2022 | 1.01 Bn |
| Sep 30, 2022 | 851.82 Mn |
| Jun 30, 2022 | 848.37 Mn |
| Mar 31, 2022 | 845.45 Mn |
| Dec 31, 2021 | 843.11 Mn |
| Sep 30, 2021 | 733.79 Mn |
| Jun 30, 2021 | 732.29 Mn |